CDK 7 Inhibitors in Immunotherapy: A New Frontier in Cancer Treatment
The combination of CDK 7 inhibitors and immunotherapy represents a novel and promising approach to cancer treatment. As research progresses, this combination therapy has the potential to improve outcomes for patients with cancers that are difficult to treat with immunotherapy alone, offeri
